clarithromycin has been researched along with sibutramine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bae, SK; Lee, SS; Pan, W; Park, SE; Park, SJ; Shim, EJ; Shin, JG; Shon, JH; Yeo, CW; Zhou, HH | 1 |
| Bae, SK; Choi, JS; Kim, DH; Kim, HS; Pan, W; Shin, JG; Shinde, DD; Shon, JH; Yeo, CW | 1 |
1 review(s) available for clarithromycin and sibutramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for clarithromycin and sibutramine
| Article | Year |
|---|---|
Different effects of clopidogrel and clarithromycin on the enantioselective pharmacokinetics of sibutramine and its active metabolites in healthy subjects.
Topics: Adult; Appetite Depressants; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Clopidogrel; Cross-Over Studies; Cyclobutanes; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Genotype; Humans; Male; Microsomes; Oxidoreductases, N-Demethylating; Polymorphism, Genetic; Stereoisomerism; Ticlopidine; Young Adult | 2013 |
2 other study(ies) available for clarithromycin and sibutramine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism.
Topics: Anti-Bacterial Agents; Appetite Depressants; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Clopidogrel; Cyclobutanes; Cytochrome P-450 CYP2B6; Humans; Male; Oxidoreductases, N-Demethylating; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Republic of Korea; Ticlopidine | 2013 |